OncoSil Medical Limited (ASX:OSL)
Australia · Delayed Price · Currency is AUD 0.7200
+0.0100 (1.41%)
At close: Feb 5, 2026
OncoSil Medical Market Cap
OncoSil Medical has a market cap or net worth of 13.6 million as of February 5, 2026. Its market cap has decreased by -40.81% in one year.
Market Cap
13.60M
Enterprise Value
8.56M
Revenue
1.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.72
Market Cap Chart
Since August 15, 2005, OncoSil Medical's market cap has increased from 7.29M to 13.60M, an increase of 86.46%. That is a compound annual growth rate of 3.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 13.60M | -25.84% |
| Dec 31, 2025 | 18.34M | -33.49% |
| Dec 31, 2024 | 27.58M | 55.21% |
| Dec 28, 2023 | 17.77M | -60.28% |
| Dec 30, 2022 | 44.74M | 25.48% |
| Dec 31, 2021 | 35.65M | -63.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CleanSpace Holdings | 50.95M |
| Nova Eye Medical | 49.84M |
| HeraMED | 45.89M |
| ImpediMed | 42.81M |
| CurveBeam AI | 37.90M |
| Atomo Diagnostics | 34.03M |
| CONNEQT Health | 27.56M |
| Control Bionics | 24.21M |